Medial Collateral Ligament Healing: a Biomechanical Assessment

Author(s):  
M. A. Gomez ◽  
M. Inoue ◽  
E. McGurk-Burleson ◽  
S. L.-Y. Woo
2006 ◽  
Vol 24 (11) ◽  
pp. 2106-2113 ◽  
Author(s):  
Rick W. Wright ◽  
Tracy Allen ◽  
Hossam B. El-Zawawy ◽  
Michael D. Brodt ◽  
Matthew J. Silva ◽  
...  

2001 ◽  
Vol 29 (6) ◽  
pp. 801-805 ◽  
Author(s):  
Christopher L. Elder ◽  
Laurence E. Dahners ◽  
Paul S. Weinhold

Celecoxib was the first of a new class of nonsteroidal antiinflammatory drugs, the cyclooxygenase-2 (COX-2) specific inhibitors, marketed as having the same antiinflammatory efficacy as other nonsteroidal antiinflammatory drugs without their increased risk of gastrointestinal ulceration. Among the widest uses of nonsteroidal antiinflammatory drugs is in the treatment of acute soft tissue injuries. Although the benefits of celecoxib have been shown when used for rheumatoid arthritis and osteoarthritis, we are unaware of any studies concerning its effect on soft tissues. We used the surgically incised medial collateral ligament of male Sprague-Dawley rats as an experimental model for acute ligament injuries to investigate the effects of celecoxib on ligament healing. Fifty rats underwent surgical transection of the right medial collateral ligament. Postoperatively, half were given celecoxib for the first 6 days of recovery, the other half were not. The animals were sacrificed 14 days after the operation, and both the injured and uninjured medial collateral ligaments were mechanically tested to failure in tension. Celecoxib-treated/injured ligaments were found to have a 32% lower load to failure than untreated/ injured ligaments. The results of this study do not support use of cyclooxygenase-2 specific inhibitors in the treatment of ligament injuries.


2011 ◽  
Vol 2 (1) ◽  
pp. 7-11
Author(s):  
Steve Wen-Neng Ueng ◽  
Mel Shiuann-Sheng Lee ◽  
Ching-Lung Tai ◽  
Kuo-Yao Hsu ◽  
Song-Shu Lin ◽  
...  

1991 ◽  
Vol 9 (4) ◽  
pp. 516-528 ◽  
Author(s):  
Jeffrey A. Weiss ◽  
Savio L-Y. Woo ◽  
Karen J. Ohland ◽  
Shuji Horibe ◽  
Peter O. Newton

1999 ◽  
Vol 360 ◽  
pp. 238-242 ◽  
Author(s):  
Paul C. Horn ◽  
Dwight A. Webster ◽  
Hesham M. Amin ◽  
Michael F. Mascia ◽  
Frederick W. Werner ◽  
...  

2005 ◽  
Vol 33 (5) ◽  
pp. 674-679 ◽  
Author(s):  
Curtis A. Hanson ◽  
Paul S. Weinhold ◽  
Hessam M. Afshari ◽  
Laurence E. Dahners

Background Studies have suggested that some nonselective nonsteroidal anti-inflammatory drugs, including piroxicam, may improve ligament healing, whereas other nonsteroidal anti-inflammatory drugs, including ibuprofen and the cyclooxygenase-2 inhibitor celecoxib, may have no effect on the mechanical properties or may even deter the healing process. These results might reflect variations in cyclooxygenase enzyme selectivity by different drugs or, alternatively, may be related to their analgesic properties because it is generally accepted that early activity improves ligament healing. Hypothesis Nonselective nonsteroidal anti-inflammatory drugs improve ligament healing, whereas other analgesics provide lesser degrees of improvement, and cyclooxygenase-2 inhibitors are detrimental. Study Design Controlled laboratory study. Methods One hundred fifty-five Sprague-Dawley rats were divided into 7 treatment groups (piroxicam, naproxen, rofecoxib, butorphanol, 2 doses of acetaminophen, and control). The right medial collateral ligament of each rat was transected, and the drugs were administered postoperatively on days 1 to 6. On day 14, the rats were sacrificed, and mechanical testing was performed on the medial collateral ligament. Results The piroxicam group demonstrated significantly greater load to failure (27%) compared with the control. No significant differences were observed between other groups. Conclusions Piroxicam improves ligament healing, but this effect cannot be attributed to all nonselective nonsteroidal anti-inflammatory drugs. Opiate analgesics, acetaminophen, and cyclooxygenase-2 inhibitors do not appear to categorically affect ligament healing. Clinical Relevance In the treatment of ligament injury, piroxicam may be a drug of choice.


2000 ◽  
Vol 8 (5) ◽  
pp. 281-285 ◽  
Author(s):  
Christopher Niyibizi ◽  
Karl Kavalkovich ◽  
Tomoo Yamaji ◽  
Savio L-Y. Woo

Sign in / Sign up

Export Citation Format

Share Document